Christer Möller

3.7k total citations · 1 hit paper
61 papers, 2.9k citations indexed

About

Christer Möller is a scholar working on Molecular Biology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Christer Möller has authored 61 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 20 papers in Physiology and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Christer Möller's work include Alzheimer's disease research and treatments (18 papers), Growth Hormone and Insulin-like Growth Factors (14 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Christer Möller is often cited by papers focused on Alzheimer's disease research and treatments (18 papers), Growth Hormone and Insulin-like Growth Factors (14 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Christer Möller collaborates with scholars based in Sweden, United States and United Kingdom. Christer Möller's co-authors include Gunnar Norstedt, Paul M. Wassarman, Lars Lannfelt, Linda Söderberg, Gunilla Osswald, Pär Gellerfors, Hanna Laudon, Malin Johannesson, Gunnar Nilsson and Patrik Nygren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Christer Möller

60 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease

2022 270 citations Linda Söderberg, Malin Johannesson et al. Neurotherapeutics profile →

Peers

Christer Möller

PHYSI

EDM

CMN

GENET

Judy H. Dunmore United States

Ritchie Williamson United Kingdom

Robert Spoelgen Germany

Donald E. Frail United States

Stefano Thellung Italy

Timothy L. Reudelhuber Canada

M. Elizabeth Ross United States

David Walker United States

Andrea Lippoldt Germany

Yelena Glinka Canada

Judy H. Dunmore United States

Christer Möller

1.4k ×1.4

1.1k ×1.1

PHYSI

202 ×0.3

EDM

336 ×1.0

CMN

460 ×1.4

GENET

Citations per year, relative to Christer Möller Christer Möller (= 1×) peers Judy H. Dunmore

Countries citing papers authored by Christer Möller

Since Specialization

Citations

This map shows the geographic impact of Christer Möller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christer Möller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christer Möller more than expected).

Fields of papers citing papers by Christer Möller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christer Möller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christer Möller. The network helps show where Christer Möller may publish in the future.

Co-authorship network of co-authors of Christer Möller

This figure shows the co-authorship network connecting the top 25 collaborators of Christer Möller. A scholar is included among the top collaborators of Christer Möller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christer Möller. Christer Möller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Andersson, Emelie, Shorena Janelidze, Gemma Salvadó, et al.. (2025). Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model mice. Nature Aging. 5(3). 366–375. 11 indexed citations

Zachrisson, Olof, Malin Johannesson, Linda Söderberg, et al.. (2025). Exidavnemab binds to aggregated α-synuclein in human brains affected by α-synucleinopathies. Neurotherapeutics. 23(1). e00779–e00779.

Johannesson, Malin, Linda Söderberg, Olof Zachrisson, et al.. (2024). Lecanemab demonstrates highly selective binding to Aβ protofibrils isolated from Alzheimer's disease brains. Molecular and Cellular Neuroscience. 130. 103949–103949. 20 indexed citations

Zachrisson, Olof, Adeline Rachalski, Eleni Gkanatsiou, et al.. (2024). Disease modifying effects of the amyloid-beta protofibril-selective antibody mAb158 in aged Tg2576 transgenic mice. Molecular and Cellular Neuroscience. 130. 103950–103950. 2 indexed citations

Söderberg, Linda, Malin Johannesson, Eleni Gkanatsiou, et al.. (2024). Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities. Scientific Reports. 14(1). 10868–10868. 22 indexed citations

Ekmark‐Lewén, Sara, Astrid Gumucio, Veronica Lindström, et al.. (2023). Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils. SHILAP Revista de lepidopterología. 4. 100086–100086. 3 indexed citations

Söderberg, Linda, Malin Johannesson, Patrik Nygren, et al.. (2022). Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease. Neurotherapeutics. 20(1). 195–206. 270 indexed citations breakdown →

Gkanatsiou, Eleni, Charlotte Sahlin, Erik Portelius, et al.. (2021). Characterization of monomeric and soluble aggregated Aβ in Down’s syndrome and Alzheimer’s disease brains. Neuroscience Letters. 754. 135894–135894. 13 indexed citations

Lindström, Veronica, Therese Fagerqvist, Eva Nordström, et al.. (2014). Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice. Neurobiology of Disease. 69. 134–143. 106 indexed citations

10.

Matzner, Ulrich, Renate Lüllmann‐Rauch, Carsten Wessig, et al.. (2005). Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy. Human Molecular Genetics. 14(9). 1139–1152. 117 indexed citations

11.

Johansson, Annika, Christer Möller, & Pauline Harper. (2003). Correction of the biochemical defect in porphobilinogen deaminase deficient cells by non-viral gene delivery. Molecular and Cellular Biochemistry. 250(1-2). 65–71. 16 indexed citations

12.

Möller, Christer, Zou Xiang, & Gunnar Nilsson. (2003). Activation of mast cells by immunoglobulin E‐receptor cross‐linkage, but not through adenosine receptors, induces A1 expression and promotes survival. Clinical & Experimental Allergy. 33(8). 1135–1140. 18 indexed citations

13.

Johansson, Annika, Christer Möller, Pär Gellerfors, & Pauline Harper. (2002). Non-viral mediated gene transfer of porphobilinogen deaminase into mammalian cells. Scandinavian Journal of Clinical and Laboratory Investigation. 62(2). 105–113. 10 indexed citations

14.

Hilding, Agneta, Christer Möller, & Kerstin Hall. (2002). Glucagon and GLP-1 stimulate IGFBP-1 secretion in Hep G2 cells without effect on IGFBP-1 mRNA. Growth Hormone & IGF Research. 12(1). 60–68. 9 indexed citations

15.

Liao, Wei, et al.. (1999). Endogenous histamine reduces plasma insulin-like growth factor I via H1 receptor-mediated pathway in the rat. European Journal of Pharmacology. 374(3). 471–476. 2 indexed citations

16.

Bieg, Sabine, Christer Möller, Tomas Olsson, & Åke Lernmark. (1997). The lymphopenia (lyp ) gene controls the intrathymic cytokine ratio in congenic BioBreeding rats. Diabetologia. 40(7). 786–792. 15 indexed citations

17.

Möller, Christer, et al.. (1994). Growth hormone regulation of lipid metabolism in cells transfected with growth hormone receptor cDNA. Molecular and Cellular Endocrinology. 99(1). 111–117. 10 indexed citations

18.

Enberg, B., et al.. (1994). Growth hormone (GH) regulation of a rat serine protease inhibitor fusion gene in cells transfected with GH receptor cDNA. Journal of Molecular Endocrinology. 12(1). 39–46. 8 indexed citations

19.

Isgaard, Jörgen, Christer Möller, Olle Isaksson, et al.. (1988). Regulation of Insulin-Like Growth Factor Messenger Ribonucleic Acid in Rat Growth Plate by Growth Hormone*. Endocrinology. 122(4). 1515–1520. 155 indexed citations

20.

Norstedt, Gunnar & Christer Möller. (1987). Growth hormone induction of insulin-like growth factor I messenger RNA in primary cultures of rat liver cells. Journal of Endocrinology. 115(1). 135–139. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact